MSF clinical trial influences new WHO tuberculosis guidelines
The World Health Organization (WHO) announced yesterday that it will update its global guidance on tuberculosis (TB) treatment as a result of a Doctors Without Borders/Médecins Sans Frontiéres clinical trial. The trial, TB PRACTECAL, is the first-ever multi-country, randomized, controlled clinical trial of a new all-oral, six-month treatment regimen to treat multi-drug-resistant tuberculosis (MDR-TB). Results…
